NGVT insider filing to sell 3,700 restricted shares valued at $194.7K
Rhea-AI Filing Summary
Ingevity Corporation (NGVT) Form 144 reports that insider Stuart E. Woodcock Jr. intends to sell 3,700 common shares on 08/11/2025 through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $194,662.55. The filing lists the securities as restricted stock that vested under a registered plan with acquisition dates of 02/27/2017, 02/27/2018 and 02/26/2020, and records a recent separate sale on 08/05/2025 of 6,720 shares for $323,904.00. Outstanding shares are shown as 36,466,285, so the planned sale represents a very small fraction of total common stock.
The notice includes the seller’s representation that they do not possess undisclosed material adverse information. The document otherwise provides routine Rule 144 disclosure details: broker, share counts, acquisition type, and prior recent sales by the same person.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small insider sale of 3,700 shares (≈$194.7K); prior 6,720-share sale noted—transaction appears immaterial to NGVT equity.
The Form 144 shows a proposed sale of 3,700 shares valued at $194,662.55 to be executed on 08/11/2025 through Morgan Stanley Smith Barney on the NYSE. With 36,466,285 shares outstanding, the sale equals roughly 0.01% of the outstanding float, indicating no obvious market-moving size. The filing documents restricted shares that vested in 2017, 2018 and 2020 and notes a prior sale on 08/05/2025 of 6,720 shares for $323,904.00. Overall, this is standard insider liquidity activity disclosed per Rule 144.
TL;DR: Filing documents sales of vested restricted awards and reiterates the seller’s certification of no material nonpublic information.
The notice identifies the securities as restricted stock vesting under a registered plan, lists the acquisition dates, specifies the broker and exchange, and includes the statutory representation that the seller lacks material nonpublic information. Those elements align with compliance expectations under Rule 144 and Exchange Act trading-plan standards. The presence of a recent prior sale is disclosed, supporting transparency about insider dispositions. No governance irregularities or unexplained transfers are evident in the document.